Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Ray Sumita, Autre. Officer active across 2 companies, notably Calithera Biosciences, Inc.. Cumulatively, 7 filings have been recorded. Split: 0 buy · 3 sells. Total volume traded: €230k. History available since 27 October 2021. The latest transaction was filed on 13 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Ray Sumita is a declarant associated with 7 filings in total. Among the 7 most recent sampled filings, they cover the period from 2021-10-29 to 2026-08-17, with EUR 230326 in sales and EUR 0 in purchases. The companies mentioned are Cue Biopharma, Inc., where the listed role is Chief Legal Compliance Officer, and Calithera Biosciences, Inc., where the listed role is See Remarks. The modal transaction nature is Disposal.